ReviewFrontiers in sleep2025
Social disadvantage, insufficient sleep, and cardiovascular disease.
Review in Frontiers in sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this paper was to search the literature examining the relationships between social disadvantage, insufficient sleep, and cardiovascular disease and conduct a brief narrative review. A sleep disparity exists in the population with poor sleep quality strongly associated with poverty. Factors such as ethnicity, annual income, education, employment, and health status significantly mediate the effect in poorer disadvantaged people. In turn, the findings from large epidemiological studies show that insufficient sleep and/or insomnia, and/or short duration sleep are linked to increased risk of cardiovascular diseases such as hypertension, coronary heart disease, heart failure, stroke, arrhythmia, and cardiovascular mortality. In addition, insomnia together with objectively assessed short sleep duration confers a higher risk of developing cardiovascular diseases. However, more large epidemiological studies controlling for obstructive sleep apnoea are needed to fully confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.